Literature DB >> 9233658

Protective and arthritis-resolving activity in sera of mice infected with Borrelia burgdorferi.

S W Barthold1, S Feng, L K Bockenstedt, E Fikrig, K Feen.   

Abstract

Transfer of immune serum from immunocompetent mice infected with B. burgdorferi protects mice against syringe challenge, and transfer of immune serum after infection is established induces arthritis resolution but does not clear infection or spirochetemia or resolve carditis. Immune serum had very-high-titer passive protective activity against syringe challenge but failed to protect mice against host-adapted spirochetes when they were challenged with infected tissue transplants. Mice were passively immunized at selected intervals relative to challenge inoculation with antisera to recombinant forms of an immunodominant region of flagellin, P39, and OspC (which are recognized by immune serum), but none provided protection or modified existing infection or disease. Results suggest that spirochetes within joints, but not in other tissues, are selectively vulnerable to immune serum and that immune serum appears to contain antibody against yet-to-be-identified antigens that may be selectively expressed in the context of joint tissue.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9233658     DOI: 10.1086/516166

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  50 in total

1.  Immunogenicity of Borrelia burgdorferi arthritis-related protein.

Authors:  Sunlian Feng; Emir Hodzic; Kimberly Freet; Stephen W Barthold
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

2.  Borrelia burgdorferi population dynamics and prototype gene expression during infection of immunocompetent and immunodeficient mice.

Authors:  Emir Hodzic; Sunlian Feng; Kim J Freet; Stephen W Barthold
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

3.  Conformational nature of the Borrelia burgdorferi decorin binding protein A epitopes that elicit protective antibodies.

Authors:  N D Ulbrandt; D R Cassatt; N K Patel; W C Roberts; C M Bachy; C A Fazenbaker; M S Hanson
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

4.  Feeding of ticks on animals for transmission and xenodiagnosis in Lyme disease research.

Authors:  Monica E Embers; Britton J Grasperge; Mary B Jacobs; Mario T Philipp
Journal:  J Vis Exp       Date:  2013-08-31       Impact factor: 1.355

5.  Relative contributions of innate and acquired host responses to bacterial control and arthritis development in Lyme disease.

Authors:  Xiaohui Wang; Ying Ma; John H Weis; James F Zachary; Carsten J Kirschning; Janis J Weis
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

6.  Specificity of infection-induced immunity among Borrelia burgdorferi sensu lato species.

Authors:  S W Barthold
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

7.  Interleukin-4 (IL-4) and IL-13 signaling pathways do not regulate Borrelia burgdorferi-induced arthritis in mice: IgG1 is not required for host control of tissue spirochetes.

Authors:  M R Potter; N Noben-Trauth; J H Weis; C Teuscher; J J Weis
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

8.  Enhanced Protective Immunogenicity of Homodimeric Borrelia burgdorferi Outer Surface Protein C.

Authors:  Diane G Edmondson; Sabitha Prabhakaran; Steven J Norris; Amy J Ullmann; Joe Piesman; Marc Dolan; Christian Probst; Christiane Radzimski; Winfried Stöcker; Lars Komorowski
Journal:  Clin Vaccine Immunol       Date:  2017-01-05

9.  Marginal zone B-cell depletion impairs murine host defense against Borrelia burgdorferi infection.

Authors:  Alexia A Belperron; Catherine M Dailey; Carmen J Booth; Linda K Bockenstedt
Journal:  Infect Immun       Date:  2007-04-30       Impact factor: 3.441

Review 10.  Reviewing molecular adaptations of Lyme borreliosis spirochetes in the context of reproductive fitness in natural transmission cycles.

Authors:  Jean I Tsao
Journal:  Vet Res       Date:  2009-04-16       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.